Omics

PerkinElmer’s Life Science and Diagnostics business has revealed its new name and branding. Revvity has now officially launched as a science-based solutions company. Based on two words, ‘revolutionise’ (rev) and ‘vita’ (vit) meaning ‘life’ in Latin, Revvity will provide reagents, consumables, assays, instruments and software to customers from pharma and biotech, diagnostic labs, academia and government […]

Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care. A key breakthrough area where big data analytics has shown tremendous scope and application is in systems biology, which has […]

Researchers have identified 35 genes associated with long-term Lyme disease that could potentially be used as biomarkers to diagnose patients with the condition.  The findings, from the Icahn School of Medicine at Mount Sinai in New York and published in the journal Cell Reports Medicine, may also lead to new therapeutic targets. The study is […]